Cisson vs. Bard: $2 Million Victory for Donna Cisson

On August 15, 2013, after about 12 hours of deliberation, the jury found for Donna Cisson in her vaginal mesh trial against manufacturer C.R.Bard Inc, and found damages in the amount of $250,000 and $1.75 million in punitive damages.  The jury found that Bard failed to provide adequate warnings as to the defects in its [...]

August 15th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Cisson vs. Bard: $2 Million Victory for Donna Cisson

Transvaginal Mesh Trials Set for Bellwether Cases

On August 5, 2013, Judge Joseph Goodwin issued pretrial Order No. 59 providing trial dates for July 14, 2014 and May 27, 2014 from the following bellwether cases. Carolyn Lewis, et al. v. Johnson & Johnson, et al., 2:12-cv-04301 TVT; Judy Brown, et al. v. Ethicon, Inc., et al., 2:12-cv-07314 TVT; Jo Huskey, et al. [...]

August 6th, 2013|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Transvaginal Mesh Trials Set for Bellwether Cases

Johnson & Johnson Recalls Another DePuy Orthopedic Product

Johnson & Johnson (J&J) is no stranger to controversy.  From being embroiled in massive litigation in DePuy ASR artificial hips, Pinnacle litigation, and in the transvaginal mesh litigation with its Ethicon Gynecare products to its multiple legal troubles and fines associated with the anti-psychotic drug Risperdal, some things do not change for J&J – they [...]

August 2nd, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Johnson & Johnson Recalls Another DePuy Orthopedic Product

Risperdal Continues to Boggle Down Johnson & Johnson

Trouble is no stranger to Johnson & Johnson.  Johnson and Johnson (J&J), embroiled in massive litigation in DePuy ASR artificial hips, and in transvaginal mesh litigation from its Ethicon Gynecare products, faces more legal issues from its anti-psychotic drug, Risperdal.  Currently, Johnson & Johnson is appealing a 1.2 billion dollar fine issued in an Arkansas [...]

June 24th, 2013|Uncategorized|Comments Off on Risperdal Continues to Boggle Down Johnson & Johnson

Ethicon Gynecare Trial Cases to be Selected on July 25, 2013

On July 25, 2013, Judge Joseph Goodwin will hear presentations submitted by counsel for consideration for selection as bellwether cases in the Johnson & Johnson Ethicon Gynecare transvaginal mesh cases.  Based on this procedure, Judge Goodwin will then select which cases will then be tried.  It is expected that he will select 5 cases from [...]

June 20th, 2013|Transvaginal Mesh|Comments Off on Ethicon Gynecare Trial Cases to be Selected on July 25, 2013

Are Too Many Doctors Simply Sales People for Big Pharma?

Big Pharma paid doctors more than $1 billion in 2012 to act in various spokesperson capacities, for travel and meals, as well as research and royalties, which is significantly more than reported in 2011.  According to a new data reported in the Financial Times, that figure only includes the 12 leading drug makers who actually [...]

May 29th, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Transvaginal Mesh|Comments Off on Are Too Many Doctors Simply Sales People for Big Pharma?

Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

Consumers injured by defective devices face an armada of attorneys as they seek to hold accountable device makers such as J&J’s hip implants DePuy ASR, DePuy Pinnacle, J&J’s transvaginal mesh product Ethicon, and Merck’s FOSAMAX that has left countless post menopausal women with atypical femur fractures.  Currently there are over 10,000 pending cases in the [...]

May 28th, 2013|Actos Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Transvaginal Mesh|Comments Off on Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?